Parnell Pharmaceuticals Holdings Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Parnell Pharmaceuticals Holdings's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2021 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Parnell Pharmaceuticals Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 21 | 34 | -1 | 15 | 0 |
| 31 Dec 20 | 30 | -15 | 14 | 0 |
| 31 Dec 19 | 29 | -7 | 16 | 0 |
| 30 Sep 19 | 28 | -3 | 12 | 0 |
| 30 Jun 19 | 25 | -7 | 12 | 0 |
| 31 Mar 19 | 27 | -2 | 12 | 0 |
| 31 Dec 18 | 27 | 0 | 12 | 0 |
| 30 Sep 18 | 25 | -13 | 9 | 0 |
| 30 Jun 18 | 22 | -15 | 9 | 0 |
| 31 Mar 18 | 22 | -16 | 10 | 0 |
| 31 Dec 17 | 20 | -23 | 20 | 0 |
| 30 Sep 17 | 21 | -12 | 16 | 0 |
| 30 Jun 17 | 22 | -15 | 20 | 0 |
| 31 Mar 17 | 18 | -23 | 24 | 0 |
| 31 Dec 16 | 20 | -22 | 27 | 0 |
| 30 Sep 16 | 20 | -27 | 31 | 0 |
| 30 Jun 16 | 17 | -23 | 30 | 0 |
| 31 Mar 16 | 17 | -20 | 31 | 0 |
| 31 Dec 15 | 17 | -14 | 24 | 0 |
| 30 Sep 15 | 11 | 6 | 11 | 0 |
| 30 Jun 15 | 8 | 7 | 14 | 0 |
| 31 Dec 14 | 8 | -14 | 11 | 0 |
| 30 Jun 14 | 8 | -17 | 8 | 0 |
| 31 Mar 14 | 10 | -7 | 7 | 0 |
| 31 Dec 13 | 6 | -9 | 6 | 0 |
Quality Earnings: Insufficient data to determine if PARN.F has high quality earnings.
Growing Profit Margin: Insufficient data to determine if PARN.F's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PARN.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare PARN.F's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if PARN.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: PARN.F has a negative Return on Equity (0%), as it is currently unprofitable.